Title : Strategic combination therapy overcomes tyrosine kinase coactivation in adrenocortical carcinoma.

Pub. Date : 2012 Dec

PMID : 23102636






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: The minimum inhibitory concentrations (IC(min)) of sunitinib quenched its primary targets: FLT-3, VEGFR-2, and RET. Sunitinib ret proto-oncogene Homo sapiens